← Back to headlines
Orum Therapeutics Receives FDA Clearance for ORM-1153 IND Application
Orum Therapeutics announced that the U.S. FDA has cleared its Investigational New Drug (IND) application for ORM-1153, a novel CD123-GSPT1 degrader-antibody conjugate.
23 Aug, 00:00 — 23 Aug, 00:00
